MOLETI, MARIA LUISA
 Distribuzione geografica
Continente #
NA - Nord America 1.349
EU - Europa 1.028
AS - Asia 374
AF - Africa 16
SA - Sud America 14
OC - Oceania 2
Totale 2.783
Nazione #
US - Stati Uniti d'America 1.323
IT - Italia 690
SG - Singapore 193
SE - Svezia 146
IN - India 86
CN - Cina 77
GB - Regno Unito 37
DE - Germania 30
CA - Canada 26
FI - Finlandia 20
RO - Romania 17
TG - Togo 15
UA - Ucraina 15
BG - Bulgaria 14
IE - Irlanda 12
RU - Federazione Russa 9
CH - Svizzera 8
ES - Italia 8
AR - Argentina 7
BR - Brasile 6
BE - Belgio 5
ID - Indonesia 5
LT - Lituania 4
NL - Olanda 4
TR - Turchia 4
AL - Albania 2
FR - Francia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
SA - Arabia Saudita 2
SI - Slovenia 2
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CL - Cile 1
HK - Hong Kong 1
IL - Israele 1
IR - Iran 1
JP - Giappone 1
MD - Moldavia 1
MY - Malesia 1
ZA - Sudafrica 1
Totale 2.783
Città #
Fairfield 186
Chandler 165
Singapore 150
Rome 127
Seattle 84
Ashburn 76
Woodbridge 70
Santa Clara 67
Houston 66
Wilmington 64
Cambridge 46
Princeton 43
Beijing 42
San Paolo di Civitate 32
Milan 31
Millbury 30
Plano 28
Lawrence 24
Naples 22
Florence 20
Ann Arbor 19
Turin 18
Bremen 16
San Diego 16
Lomé 15
Toronto 15
Sofia 14
Helsinki 13
Bari 12
Boston 12
Dublin 12
Ottawa 11
Palermo 11
Andover 10
New York 10
Venice 10
Bologna 9
Norwalk 9
Atella 8
Carmarthen 8
Catania 8
Des Moines 8
Birkenhead 7
Federal 7
Moscow 7
Genoa 6
Arluno 5
Columbus 5
Jakarta 5
Madrid 5
Montopoli in Val d'Arno 5
Southend 5
Brussels 4
Buffalo 4
Bühl 4
Jacksonville 4
London 4
Timisoara 4
Voghera 4
Belo Horizonte 3
Bern 3
Brookline 3
Cattolica 3
Conegliano 3
Dearborn 3
Fonte Nuova 3
Frankfurt am Main 3
Hefei 3
Los Angeles 3
Mondovì 3
Monte Porzio 3
Montesilvano Marina 3
Pavia 3
Perugia 3
Pisa 3
Pune 3
Redmond 3
San Giuseppe Vesuviano 3
Tortoreto 3
Afragola 2
Amelia 2
Angeles City 2
Ankara 2
Arezzo 2
Barcelona 2
Bevagna 2
Bonate Sopra 2
Brugherio 2
Cagliari 2
Cascina 2
Castel Ritaldi 2
Caulonia 2
Cesenatico 2
Città Sant'Angelo 2
Cwmbran 2
Grassobbio 2
Gravina in Puglia 2
Gualtieri 2
Istanbul 2
Kunming 2
Totale 1.824
Nome #
Esperienza con l'imatinib ad intermittenza nei bambini e adolescenti con leucemia mieloide cronica (LMC): risultati e prospettive 215
Terapia con Idrossiurea in bambini e adolescenti affetti da anemia falciforme nel “real life setting 154
LOCALIZZAZIONE EXTRAMIDOLLARE DI LAM IN ETÀ PEDIATRICA: IL RUOLO DI UNA CORRETTA E TEMPESTIVA DIAGNOSI 131
Treatment-free remission after imatinib discontinuation is possible in paediatric patients with chronic myeloid leukaemia. 109
Epstein-Barr virus–positive diffuse large B-cell lymphoma in children: a disease reminiscent of Epstein-Barr virus–positive diffuse large B-cell lymphoma of the elderly 96
Atypical chronic myeloid leukemia in a patient with aplastic anemia 92
Early response does not predict outcome in children and adolescents with chronic myeloid leukaemia treated with high-dose imatinib 89
EFFICACIA DEL PEG-IFNΑ-2A IN UN CASO DI POLICITEMIA VERA PEDIATRICA 86
Real-Life Management of Children and Adolescents with Chronic Myeloid Leukemia: The Italian Experience 83
INDOMETHACIN AS FIRST LINE TREATMENT OF LANGERHANS CELL HISTIOCYTOSIS (LCH). A 20-YEAR EXPERIENCE OF A SINGLE CENTRE. 78
Can chronic myeloid leukaemia in children and adolescents be successfully treated without haematopoietic stem cell transplant? A single centre experience 77
Gamma-delta hepatosplenic T-cell lymphoma. Description of a case with immunophenotypic and molecular follow-up succesfully treated with chemotherapy alone 72
EFFICACIA E SICUREZZA DELL’IMPIEGO DEI PICC IN PAZIENTI PEDIATRICI AFFETTI DA LEUCEMIA ACUTA: ESPERIENZA MONOCENTRICA 69
Specific guidelines including multidisciplinary approach is critical of management of Langerhans Cell Histiocytosis in adults 65
null 64
Intermittent Imatinib mesylate in children with chronic myeloid leukemia: results and outcome 64
Management of Chronic Myeloid Leukemia in children and adolescents according to local guidelines the Italian experience 61
Proven Epstein-Barr encephalitis with negative EBV-DNA load in cerebrospinal fluid after allogeneic hematopoietic stem cell transplantation in a child with acute lymphoblastic leukemia 59
Second cancer incidence in primary mediastinal B-cell lymphoma treated with methotrexate with leucovorin rescue, doxorubicin, cyclophosphamide, vincristine, prednisone, and bleomycin regimen with or without rituximab and mediastinal radiotherapy. results from a monoinstitutional cohort analysis of long-term survivors 59
Early Response Does Not Impact on the Long-Term Outcome of Children and Adolescents with Chronic Myeloid Leukemia Treated with High-Dose Imatinib. The Italian Experience. 58
Polyostotic Fibrous Dysplasia Mimicking Bone Involvement in Hodgkin Lymphoma: A Pediatric Case and Literature Review 55
Response to High Dose Imatinib and Long-Term Outcome in Children and Adolescents with Previously Untreated Chronic Myeloid Leukemia in Chronic Phase. the Italian Experience. 53
Next-Generation Sequencing (NGS) in childhood Myeloproliferative Diseases (MPD) 53
Applicazione della classificazione WHO 2016 IN 80 bambini e adolescenti con neoplasie mieloproliferative croniche 52
Trombocitopenia Idiopatica (ITP) cronica. cosa puo’ nascondere? 52
Chronic Thrombocytopenia in Children: What Could It Hide? 52
Autoimmune Hemolitic Anemia in a Boy With Inactive Ulcerative Colitis 49
Severe rituximab-induced pneumonitis in an immunocompromised child with acquired thrombotic thrombocytopenic purpura 49
UTILITA’ DELLA TECNICA NEXT GENERATION SEQUENCING (NGS) NELL’IDENTIFICAZIONE DI GENI NON-DRIVER IN PAZIENTI CON MALATTIE MIELOPROLIFERATIVE CRONICHE (MMC) PEDIATRICHE WILD TYPE: ESPERIENZA DI UN SINGOLO CENTRO 48
Results and outcome of intermittent imatinib (ON/OFF schedule) in children and adolescents with chronic myeloid leukaemia 47
EFFICACY OF INDOMETHACIN AS SALVAGE THERAPY IN CHILDREN AND ADULTS WITH LANGERHANS CELL HISTIOCYTOSIS WITH BONE INVOLVEMENT 45
Iron deficiency in children and adolescents: an alarm bell for gastrointestinal diseases. 44
null 43
Managing Children and Adolescents with Chronic Myeloid Leukemia Treated with High-Dose Imatinib. The Italian Experience. 41
Primary Trombocythemia in Children and Adolescents Includes Different Subtypes Compared to Adult Essential Thrombocythemia 40
Long-term Outcome in Children and Adolescents with Chronic Myeloid Leukemia in Chronic Phase Treated with High-Dose Imatinib. The Italian Experience. 38
Incidence and outcome of infections after unrelated cord blood transplantation in patients with hematological malignancies: a long-term single center experience 37
Discontinuation of Imatinib (IM) in pediatrica chronic myeloid leukemia (CML) patients with sustained complete molecular remission (CMR). 36
Reduced mortality from KPC-K.pneumoniae bloodstream infection in high-risk patients with hematological malignancies colonized by KPC-K.pneumoniae 35
Efficacy of ibrutinib as salvage treatment in a secondary central nervous system lymphoma (SCNSL) progressed after chemorefractory Primary Mediastinal B Cell Lymphoma (PMBCL) 33
P1580: MANAGEMENT OF PATIENTS WITH MASTOCYTOSIS DURING THE COVID-19 PANDEMIC: A SINGLE CENTER EXPERIENCE 30
A long-term outcome for patients with high-risk leukemia undergoing an unrelated cord blood transplant (CBT) 29
P1006: NEXT GENERATION SEQUENCING (NGS) IN PEDIATRIC MASTOCYTOSIS 29
P981: NEXT GENERATION SEQUENCING (NGS): AN IMPORTANT TOOL TO CHARACTERIZE MYELOPROLIFERATIVE DISEASES IN CHILDREN 28
null 27
WHO 2016 classification in 80 children and adolescents with chronic myeloproliferative neoplasms 27
Acquired thrombotic thrombocytopenic purpura in a child: Rituximab to prevent relapse. A pediatric report and literature review 24
Fifteen years of iodine prophylaxis in Italy. Results of a nationwide surveillance (Period 2015-2019) 19
Challenging Management of Severe Differentiation Syndrome in Pediatric Acute Promyelocytic Leukemia Treated with ATRA/ATO 19
null 18
Long-term results with the adapted LMB 96 protocol in children with B-cell non Hodgkin lymphoma treated in Iraq: comparison in two subsequent cohorts of patients 16
LAL PH+ IN ETÀ PEDIATRICA: VALUTAZIONE DELLA MALATTIA MINIMA RESIDUA E RUOLO DELLA TERAPIA CON INIBITORI DELLA TIROSINCHINASI (TKI) 16
Benefits and Safety of Empiric Antibiotic Treatment Active Against KPC-K. pneumoniae in Febrile Neutropenic Patients with Acute Leukemia Who are Colonized with KPC-K. pneumoniae. A 7-Years Retrospective Observational Cohort Study 13
HODGKIN LYMPHOMA IN CHILDREN: A 16-YEAR EXPERIENCE AT THE CHILDREN’S WELFARE TEACHING HOSPITAL OF BAGHDAD, IRAQ 7
Benefits and Safety of Empiric Antibiotic Treatment Active Against KPC-Producing Klebsiella pneumoniae for Febrile Neutropenic Episodes in Colonized Children with Acute Leukemia—An 8-Year Retrospective Observational Study 6
null 3
Totale 2.994
Categoria #
all - tutte 8.293
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.293


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020287 0 0 0 0 0 61 45 47 43 40 27 24
2020/2021193 15 15 4 17 21 3 10 22 38 14 21 13
2021/2022419 20 18 21 26 66 27 6 35 32 23 71 74
2022/2023596 85 93 36 73 65 71 7 36 82 9 18 21
2023/2024557 34 44 40 39 50 28 34 33 19 99 54 83
2024/2025550 86 140 60 76 115 73 0 0 0 0 0 0
Totale 2.994